Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
PaperCitations, authors & open-access status
FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 26 citations, 2022 year and gold oa status.
26
Citations
2022
Year
gold
OA Status